CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 6.59: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.09BUSDvs all stocks (USD)
Revenue (TTM)
357.28MUSDvs all stocks (USD)
Profit Margin
-5.43%vs Diagnostics & Research peers
Beta
0.9960xvs all stocks
52-Week Change
60.15%vs all stocks
Market Capitalization
1.09BUSDvs all stocks (USD)
Enterprise Value
844.88MUSDvs all stocks (USD)
Forward P/E
-35.59xvs Diagnostics & Research peers
Price to Sales (TTM)
3.01xvs Diagnostics & Research peers
Price to Book (MRQ)
2.28xvs Diagnostics & Research peers
Enterprise to Revenue
2.37xvs Diagnostics & Research peers
Enterprise to EBITDA
-51.16xvs Diagnostics & Research peers
Gross Margin
77.11%vs Diagnostics & Research peers
Profit Margin
-5.43%vs Diagnostics & Research peers
Operating Margin
-2.96%vs Diagnostics & Research peers
Return on Assets (TTM)
-1.36%vs Diagnostics & Research peers
Return on Equity (TTM)
-4.20%vs Diagnostics & Research peers
Revenue (TTM)
357.28MUSDvs all stocks (USD)
Revenue per Share (TTM)
12.04USDUpdated Sep 27, 2026Quarterly Revenue Growth
20.10%vs Diagnostics & Research peers
Gross Profit (TTM)
276.03MUSDvs all stocks (USD)
EBITDA (TTM)
9.88MUSDvs all stocks (USD)
Net Income (TTM)
-19.41MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
20.14%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
42.63MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-7.26MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
344.23MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
71.03MUSDFY2025 · Dec 31, 2025Gross Profit
273.20MUSDFY2025 · Dec 31, 2025Operating Income
-42.81MUSDvs all stocks (USD)
Pre-tax Income
-29.51MUSDFY2025 · Dec 31, 2025Income Tax Expense
-5.36MUSDFY2025 · Dec 31, 2025Net Income
-24.16MUSDFY2025 · Dec 31, 2025EBIT
-29.43MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
9.88MUSDFY2025 · Dec 31, 2025Research & Development
51.85MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
229.32MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
11.77MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
86.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.8300USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.8300USDFY2025 · Dec 31, 2025Basic Shares Outstanding
28.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
28.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-24.16MUSDFY2025 · Dec 31, 2025Operating Cash Flow
63.97MUSDFY2025 · Dec 31, 2025Free Cash Flow
28.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
116.73MUSDFY2025 · Dec 31, 2025Income Tax Paid
1.60MUSDFY2025 · Dec 31, 2025Interest Paid
59.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-24.16MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
40.77MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-6.23MUSDFY2025 · Dec 31, 2025Stock-based Compensation
45.89MUSDFY2025 · Dec 31, 2025Other Non-cash Items
153.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
6.88MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.08MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.41MUSDFY2025 · Dec 31, 2025Capital Expenditures
-35.98MUSDFY2025 · Dec 31, 2025Net Acquisitions
-18.73MUSDFY2025 · Dec 31, 2025Purchase of Investments
-188.71MUSDFY2025 · Dec 31, 2025Sale of Investments
190.73MUSDFY2025 · Dec 31, 2025Other Investing Activity
-7.68MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-60.37MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
190.00KUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-115.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-11.66MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-11.58MUSDFY2025 · Dec 31, 2025Shares Outstanding
30.51MSharesUpdated Sep 27, 2026Float Shares
27.14MSharesUpdated Sep 27, 2026Shares Short
1.90MSharesUpdated Sep 27, 2026Short Ratio
5.73daysvs all stocks
Short % of Shares Outstanding
6.37%vs all stocks
% Held by Insiders
2.42%vs all stocks
% Held by Institutions
91.01%vs all stocks
Total Cash (MRQ)
266.80MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
8.73USDUpdated Sep 27, 2026Total Debt (MRQ)
36.65MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0780xvs Diagnostics & Research peers
Current Ratio (MRQ)
6.04xvs Diagnostics & Research peers
Book Value per Share (MRQ)
15.41USDUpdated Sep 27, 2026Total Assets
578.56MUSDvs all stocks (USD)
Total Current Assets
361.10MUSDFY2025 · Dec 31, 2025Total Liabilities
107.68MUSDFY2025 · Dec 31, 2025Total Non-current Assets
217.46MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
39.01MUSDFY2025 · Dec 31, 2025Total Current Liabilities
68.68MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
116.73MUSDFY2025 · Dec 31, 2025Other Short-term Investments
182.78MUSDFY2025 · Dec 31, 2025Accounts Receivable
43.38MUSDFY2025 · Dec 31, 2025Inventory
10.25MUSDFY2025 · Dec 31, 2025Accounts Payable
18.71MUSDFY2025 · Dec 31, 2025Short-term Debt
1.74MUSDFY2025 · Dec 31, 2025Other Current Liabilities
3.13MUSDFY2025 · Dec 31, 2025Long-term Debt
35.17MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.50MUSDFY2025 · Dec 31, 2025Common Stock (Book)
30.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-224.28MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
470.87MUSDvs all stocks (USD)
52-Week Low
17.72USDUpdated Sep 27, 202652-Week High
44.28USDUpdated Sep 27, 202652-Week Change
60.15%vs all stocks
Beta
0.9960xvs all stocks
50-Day MA
31.01USDUpdated Sep 27, 2026200-Day MA
29.17USDUpdated Sep 27, 2026Avg 10-Day Volume
397.35KSharesUpdated Sep 27, 2026Avg 30-Day Volume
355.04KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-0.6400USDUpdated Sep 27, 2026Other Income / Expense
1.61MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.77Profit Margin: -0.05
Financial Health
Altman Z-Score 6.59: safe zoneNotable
Altman Z-Score: 6.59
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Hangzhou Cogeneration Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangxi Black Cat Carbon Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yapp Automotive Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Kaisheng New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shin Zu Shing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Metsä Board Oyj B
Tier 1ProductionThroughput-Bound ConversionFlowRule
KBC Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Wuxi Xinje Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ckd Corp
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Keli Motor Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Palantir Technologies Inc.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Guangdong Hybribio Biotech Co., Ltd.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Zhongwang Fabric Co. Ltd.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration